NORTHPOINTE CAPITAL LLC - SUPERNUS PHARMACEUTICALS INC ownership

SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 90 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q2 2014. The put-call ratio across all filers is 0.12 and the average weighting 0.5%.

Quarter-by-quarter ownership
NORTHPOINTE CAPITAL LLC ownership history of SUPERNUS PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2018$1,170,000
-58.2%
35,222
-36.6%
0.26%
-34.7%
Q3 2018$2,799,000
-20.2%
55,595
-5.1%
0.40%
-13.1%
Q2 2018$3,506,000
-49.4%
58,587
-61.3%
0.46%
-46.4%
Q1 2018$6,935,000
-27.5%
151,409
-36.9%
0.87%
-19.0%
Q4 2017$9,560,000
-5.0%
239,897
-4.6%
1.07%
-0.4%
Q3 2017$10,061,000
-15.9%
251,526
-9.4%
1.08%
-14.2%
Q2 2017$11,970,000
-10.2%
277,726
-34.8%
1.25%
-13.8%
Q1 2017$13,334,000
-0.4%
425,997
-19.7%
1.45%
+9.2%
Q4 2016$13,387,000
-12.0%
530,183
-13.8%
1.33%
-15.5%
Q3 2016$15,210,000
-1.9%
615,061
-19.2%
1.58%
-13.9%
Q2 2016$15,506,000
+31.8%
761,203
-1.3%
1.83%
+25.4%
Q1 2016$11,764,000
+43.4%
771,419
+31.9%
1.46%
+35.5%
Q4 2015$8,204,0000.0%584,7530.0%1.08%
+0.8%
Q3 2015$8,204,000
-45.6%
584,753
-34.2%
1.07%
-39.8%
Q2 2015$15,090,000
+3.3%
888,679
-26.4%
1.78%
+12.3%
Q1 2015$14,608,000
+79.4%
1,208,258
+23.2%
1.58%
+61.7%
Q4 2014$8,143,000
-17.4%
981,062
-13.5%
0.98%
-6.5%
Q3 2014$9,858,000
-11.7%
1,134,447
+11.2%
1.05%
-3.0%
Q2 2014$11,167,000
+16.8%
1,019,819
-4.7%
1.08%
+11.1%
Q1 2014$9,564,0001,069,8980.97%
Other shareholders
SUPERNUS PHARMACEUTICALS INC shareholders Q2 2014
NameSharesValueWeighting ↓
ASHFORD CAPITAL MANAGEMENT INC 698,676$41,816,0005.51%
Provident Investment Management, Inc. 543,194$32,510,0004.61%
NEUMEIER POMA INVESTMENT COUNSEL LLC 426,250$25,511,0002.37%
KOPP INVESTMENT ADVISORS LLC 41,879$2,506,0002.35%
AlphaOne Investment Services, LLC 126,279$7,558,0002.17%
Ranger Investment Management 468,933$28,066,0001.96%
Bruce & Co., Inc. 158,058$9,459,0001.88%
Penserra Capital Management LLC 244,371$29,030,0001.83%
SHAKER INVESTMENTS LLC/OH 49,642$2,971,0001.83%
Bridge City Capital, LLC 47,795$2,861,0001.81%
View complete list of SUPERNUS PHARMACEUTICALS INC shareholders